Generics Behaving Badly: Carve Outs, Off-Label Uses
Patents have long been the crown jewels of the pharma industry. They protect pioneer therapies from generic competition and underwrite the enormous investment required for new drug research and development....To view the full article, register now.
Already a subscriber? Click here to view full article